Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Metabolic Syndrome; Diabetes; Prediabetes; Hypertension
Intervention:
Sponsor: West Virginia School of Osteopathic Medicine
Not yet recruiting - verified March 2010
Condition: Coronary Artery Disease
Intervention: Drug: Omacor, omega-3 fatty acids in CAD patients
Sponsors: HeartDrug Research LLC; University of Oslo
Not yet recruiting - verified March 2010
Conditions: Type 2 Diabetes; Exercise
Interventions: Behavioral: Exercise on Prescription; Behavioral: Nordic Walking
Sponsors: Hospital of South West Denmark; University of Southern Denmark
Completed - verified January 2005
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Conditions: Diabetes Type 2; Obesity
Intervention:
Sponsor: Malmö University Hospital
Completed - verified December 2009
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Conditions: Type 2 Diabetes; Morbid Obesity
Intervention:
Sponsor: University Hospital, Gasthuisberg
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: NOX-E36; Drug: NOX-E36
Sponsors: Noxxon Pharma AG; Profil Institut für Stoffwechselforschung GmbH
Not yet recruiting - verified March 2010
Condition: Hypercholesterolemia
Intervention: Drug: Simvastatin
Sponsor: Hadassah Medical Organization
Not yet recruiting - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin; Drug: placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Behavioral: Diabetes related psychological counseling and education; Device: Continuous Glucose Monitor
Sponsors: University Hospital Case Medical Center; National Institute of Mental Health (NIMH)
Not yet recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: AZD1656; Drug: Gemfibrozil; Drug: Placebo
Sponsor: AstraZeneca
Not yet recruiting - verified March 2010
Conditions: Healthy; Overweight; Obesity
Intervention: Procedure: Dietary and Exercise Intervention
Sponsors: National University Hospital, Singapore; National Medical Research Council (NMRC), Singapore
Not yet recruiting - verified March 2010
Conditions: Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet Therapy
Interventions: Procedure: Roux-en-Y Gastric Bypass; Behavioral: Caloric Restriction
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Diabetic Vascular Complications
Intervention:
Sponsor: Winthrop University Hospital
Recruiting - verified March 2010
Conditions: Atherosclerosis; Hypercholesterolemia
Interventions: Drug: BMS-844421; Drug: 0.9% sodium chloride injection solution
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: AZD1656; Drug: Pioglitazone
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE; Drug: INSULIN GLULISINE
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg; Drug: Placebo/sitagliptin 2x50 mg; Drug: Canagliflozin 300 mg
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Hypercholesterolemia
Interventions: Drug: atorvastatin; Drug: atorvastatin
Sponsor: Yonsei University
Completed - verified January 2010
Condition: Diabetes Mellitus
Interventions: Device: Finesse; Device: Pen/Syringe (Usual injection device)
Sponsors: Calibra Medical, Inc.; Nancy Bohannon, MD, Med. Corp.; Henry Ford Health System; Northwestern University; University of Texas Southwestern Medical Center; Joslin Diabetes Center; International Diabetes Center at Park Nicollet
Recruiting - verified March 2010
Condition: Insulin Resistance
Intervention:
Sponsors: Children's Hospital Boston; University of Massachusetts
Recruiting - verified March 2010
Condition: Diabetes
Intervention:
Sponsor: Beth Israel Deaconess Medical Center
Recruiting - verified March 2010
Condition: Fanconi Anemia
Interventions: Drug: Chemotherapy Preparative Regimen; Biological: Miltenyi CliniMACS
Sponsor: Children's Hospital Medical Center, Cincinnati
Recruiting - verified March 2010
Condition: Phenylketonuria
Intervention: Drug: Kuvan® (Sapropterin dihydrochloride)
Sponsors: Merck KGaA; Smerud Medical Research International AS
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
Interventions: Drug: SB-509; Other: Saline
Sponsors: Sangamo Biosciences; Juvenile Diabetes Research Foundation
Recruiting - verified March 2010
Conditions: Diabetes; Obesity
Intervention: Behavioral: Lifestyle Intervention Classes
Sponsors: Emory University; American Diabetes Association; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified January 2010
Conditions: Diabetes; Cataract
Intervention:
Sponsor: Frederiksberg University Hospital
Completed - verified August 2009
Condition: Hypertension
Intervention:
Sponsor: Abbott
Completed - verified March 2010
Conditions: Diabetes Mellitus 1 or 2; Midfoot Charcot Neuroarthropathy
Interventions: Procedure: Surgery with Midfoot Fusion Bolt; Procedure: Cast treatment
Sponsor: AO Clinical Investigation and Documentation
Not yet recruiting - verified March 2010
Condition: Lipid Metabolism Disorder
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Conditions: Metabolic Syndrome; Hypercholesterolemia
Intervention: Drug: Metformin
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Conditions: HIV Infection; Antiretroviral Side Effects; Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
Sponsor: Assistance Publique - Hôpitaux de Paris
Completed - verified January 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: repaglinide
Sponsor: Novo Nordisk
Not yet recruiting - verified February 2010
Condition: Familial Hypercholesterolaemia
Interventions: Drug: rosuvastatin calcium; Drug: rosuvastatin calcium; Drug: rosuvastatin calcium
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Corneal Dystrophy
Intervention:
Sponsor: Frederiksberg University Hospital
Recruiting - verified January 2010
Condition: Type 2 Diabetes
Interventions: Drug: exenatide; Drug: Other antidiabetic therapies; Other: No diabetes therapy
Sponsors: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Completed - verified February 2010
Condition: Diabetes Type 2
Interventions: Drug: Insulin-Levemir; Drug: Exenatide-Bayetta; Drug: Insulin-Levemir and Exenatide-Bayetta; Device: SenseWear Pro3® armband; Device: DexCom CGM
Sponsors: Novo Nordisk; BodyMedia
Recruiting - verified June 2009
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin glulisine; Drug: Insulin glargine; Drug: Premixed insulin (Insulin Aspart 30/70 )
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Type II Diabetes Mellitus
Intervention: Other: Spice polyphenols
Sponsor: University of California, Los Angeles
Recruiting - verified February 2010
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib; Drug: dexamethasone; Drug: melphalan
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes
Intervention:
Sponsors: China Cardiometabolic Registries; Roche Pharma AG; VitalStrategic Research Institute; Chinese College of Cardiovascular Physicians; China Endocrinologist Association
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: NN1250
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate; Drug: Comparator: placebo to pioglitazone; Drug: Comparator: placebo to sitagliptin; Drug: Comparator: pioglitazone; Drug: Comparator: glimepiride or gliclazide; Drug: Comparator: metformin; Drug: Comparator: pioglitazone rescue therapy
Sponsor: Merck
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus
Intervention: Device: FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5
Sponsor: Abbott Diabetes Care
Completed - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate (+) metformin hydrochloride; Drug: Comparator: metformin; Drug: Comparator: sitagliptin; Drug: Comparator: Placebo
Sponsor: Merck
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus
Interventions: Device: cell phone delivered tele-educational; Device: cell phone
Sponsors: Walter Reed Army Medical Center; Affinity Networks Inc.
Active, not recruiting - verified June 2009
Condition: Gaucher Disease
Interventions: Drug: Genz-112638; Drug: Genz-112638
Sponsor: Genzyme
Not yet recruiting - verified January 2010
Condition: Type 1 Diabetes
Interventions: Other: Closed-loop insulin delivery; Other: Standard insulin pump treatment
Sponsors: University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Not yet recruiting - verified February 2010
Conditions: Diabetes Mellitus; Quality of Health Care; Health Services Research
Intervention: Behavioral: Structured personal care
Sponsor: Research Unit Of General Practice, Copenhagen
Completed - verified July 2003
Conditions: Insulin Resistance; Glucose Intolerance
Interventions: Drug: Colecalciferol (Vitamin D3) 300.000 UI; Drug: Placebo
Sponsor: Hospital de Clinicas de Porto Alegre
Enrolling by invitation - verified February 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Diabetes, Gestational
Intervention:
Sponsor: University of Cincinnati
Enrolling by invitation - verified February 2010
Conditions: Hyperkalaemia Requiring Postoperative Dialysis; Metabolic Acidosis
Intervention:
Sponsor: Medical University of Vienna
Not yet recruiting - verified January 2010
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine); Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
Sponsor: Sheba Medical Center
Not yet recruiting - verified February 2010
Conditions: Pregnancy; Helicobacter Pylori Infection; Iron-Deficiency Anemia
Intervention:
Sponsor: E-DA Hospital
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Behavioral: Lifestyle counseling; Behavioral: Standard care
Sponsor: The Catholic University of Korea
Recruiting - verified December 2007
Condition: Dyslipidemia
Intervention:
Sponsor: AstraZeneca
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Other: SMBG to guide clinical decisions; Other: SMBG and CGM
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Abbott Diabetes Care
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: ASP1941; Drug: Metformin; Drug: Placebo
Sponsor: Astellas Pharma Inc
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MP-513; Drug: MP-513; Drug: Placebo of MP-513
Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting - verified February 2010
Condition: Hypercholesterolemia
Intervention: Drug: Niacin\Laropiprant
Sponsor: Rambam Health Care Campus
Not yet recruiting - verified February 2010
Conditions: Hyperphosphatemia; End-Stage Renal Disease
Intervention: Drug: ferric citrate
Sponsor: Keryx Biopharmaceuticals
Not yet recruiting - verified February 2010
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
Sponsor: Sheba Medical Center
Not yet recruiting - verified February 2010
Condition: Hypercholesterolemia
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Dyslipidemia
Interventions: Drug: Niaspan; Drug: Comparator: Placebo
Sponsor: Merck
Recruiting - verified February 2010
Conditions: Heart Failure; Type 2 Diabetes
Intervention: Drug: insulin
Sponsors: University of Aarhus; Danish Heart Foundation; Region midtjyllands sundhedsvidenskabelige forskningsfond
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Intervention: Dietary Supplement: Isomaltulose
Sponsors: University of Giessen; Numico Research
Completed - verified November 2002
Conditions: Type 2 Diabetes Mellitus; Obesity
Interventions: Procedure: Laparoscopic Adjustable Gastric Band; Procedure: Roux-en-Y Gastric Bypass (Surgery); Other: Intensive Medical Diabetes & Weight Management; Device: Allergan Adjustable Gastric Band
Sponsors: Joslin Diabetes Center; Brigham and Women's Hospital
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type II
Intervention:
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - verified January 2010
Condition: Diabetes Mellitus
Interventions: Drug: BGP-15 100 mg QD; Drug: BGP-15 100 mg BID; Drug: Placebo BID; Drug: BGP-15 200 mg QD; Drug: BGP-15 200 mg BID; Drug: BGP-15 400 mg QD
Sponsors: N-Gene Research Laboratories, Inc.; Integrium; Msource Medical Development GmbH; Kinexum LLC; Fisher Clinical Services UK Ltd; Haupt Pharma Wülfing GmbH; BARC nv
Not yet recruiting - verified February 2010
Condition: Type 1 Diabetes
Intervention: Biological: Mesenchymal stem cells
Sponsor: Uppsala University Hospital
Not yet recruiting - verified February 2010
Condition: Glucose Lowering
Intervention: Drug: AZD1656
Sponsor: AstraZeneca
Not yet recruiting - verified February 2010
Condition: Dyslipidemia
Interventions: Drug: A3309; Drug: A3309; Drug: Placebo
Sponsor: Albireo
Recruiting - verified February 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Conditions: Hyperphosphatemia; Chronic Kidney Disease
Interventions: Drug: SBR759A; Drug: SBR759A; Drug: SBR759A; Drug: SBR759A; Drug: SBR759A
Sponsor: Novartis
Not yet recruiting - verified February 2010
Condition: Primary Systemic Amyloidosis
Interventions: Drug: bortezomib; Drug: cyclophosphamide; Drug: dexamethasone
Sponsor: Mayo Clinic
Not yet recruiting - verified February 2010
Condition: Minimal Hepatic Encephalopathy
Interventions: Drug: Rifaximin; Drug: rifaximin
Sponsors: Hunter Holmes Mcguire Veteran Affairs Medical Center; Salix Pharmaceuticals
Recruiting - verified February 2010
Conditions: Metabolic Syndrome; Obesity; Diabetes; Cardiovascular Disease
Interventions: Behavioral: Crononutrition; Behavioral: American Heart Association
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Hospital of Navarra
Recruiting - verified March 2010
Condition: Nonalcoholic Fatty Liver Disease
Intervention: Drug: Metformin
Sponsor: Wolfson Medical Center
Completed - verified March 2010
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Galvus (vitagliptin); Drug: Galvus + vitamin D
Sponsor: Ziv Hospital
Not yet recruiting - verified March 2010
Condition: Parkinson's Disease
Intervention:
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified March 2010
Condition: Prostatic Cancer
Intervention: Drug: epidural infusion of saline, ropivecaine, or ropivacaine and sufentanil
Sponsor: Yonsei University
Recruiting - verified March 2010
Condition: Scalp Psoriasis
Intervention: Drug: LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)
Sponsor: LEO Pharma
Not yet recruiting - verified March 2010
Conditions: Obstructive Sleep Apnea; Obesity
Interventions: Procedure: Bariatric surgery; Device: Continuous positive airway pressure
Sponsors: Kuopio University Hospital; Helsinki University Central Hospital; Turku University Hospital; Oulu University Hospital; Vaasa Central Hospital, Vaasa, Finland; National Institute for Health and Welfare, Finland; Helsinki Sleep Clinic; Päijät-Häme Central Hospital,Lahti
Not yet recruiting - verified March 2010
Condition: Prostate Cancer
Intervention: Dietary Supplement: Olive Oil
Sponsors: Brown University; The Miriam Hospital
Recruiting - verified October 2009
Conditions: Morbid Obesity; Overweight; Normal Weight
Intervention: Procedure: Surgery
Sponsors: Fundacion IMIM; Parc de Salut Mar
Recruiting - verified October 2009
Condition: Adult Growth Hormone Deficiency
Intervention:
Sponsor: Merck KGaA
Active, not recruiting - verified March 2010
Conditions: Obesity; Metabolic Syndrome
Intervention:
Sponsor: Shanghai Jiao Tong University School of Medicine
Recruiting - verified March 2010
Condition: Acute Lymphoblastic Leukemia
Intervention:
Sponsor: Samsung Medical Center
Recruiting - verified March 2010
Condition: Pulmonary Arterial Hypertension (Idiopathic, Familial or Anorexigen-associated)
Interventions: Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium
Sponsors: University of Alberta; Imperial College London
Enrolling by invitation - verified March 2010
Condition: Liver Cancer
Interventions: Drug: temsirolimus; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: quality-of-life assessment; Radiation: fludeoxyglucose F 18
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified March 2010
Condition: Polycystic Ovary Syndrome
Intervention: Behavioral: Nutrition Education, Dietary Counseling, and Cooking
Sponsors: Children's Hospital Boston; Thrasher Research Fund
Not yet recruiting - verified March 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Conditions: Hypertension; Metabolic Syndrome
Intervention:
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not yet recruiting - verified March 2010
Condition: Diabetes in Cystic Fibrosis Patients
Intervention: Other: Prospective cohort with an annual follow-up
Sponsor: Hospices Civils de Lyon
Recruiting - verified October 2009
Conditions: Active Rheumatoid Arthritis; Osteoporoses
Intervention:
Sponsors: Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic
Recruiting - verified February 2010
Condition: Healthy Volunteers
Interventions: Dietary Supplement: Single High Dose Cholecalciferol; Dietary Supplement: Daily Dose Cholecalciferol
Sponsor: Mayo Clinic
Recruiting - verified March 2010
Conditions: Sarcopenia; Osteoporosis; Aging
Interventions: Drug: Acetaminophen; Drug: Ibuprofen; Behavioral: high intensity progressive resistance exercise training; Drug: placebo
Sponsor: University of Colorado, Denver
Active, not recruiting - verified March 2010
Condition: Schizophrenia
Intervention:
Sponsors: National Taiwan University Hospital; National Science Council, Taiwan
Enrolling by invitation - verified February 2010
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: University of Oulu; Pfizer
Recruiting - verified February 2010
Condition: Pregnancy
Intervention:
Sponsor: Universitaire de Sherbrooke
Recruiting - verified February 2010
Condition: Foot Ulcer, Diabetic
Intervention: Drug: N-acetylcysteine
Sponsor: University of Turin, Italy
Completed - verified February 2010
Condition: Pain, Postoperative
Interventions: Drug: continuous ropivacaine preperitoneal infusion; Drug: intravenous lidocaine infusion; Drug: parenteral analgesia combining acetaminophen and morphine; Drug: NaCl
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2010
Condition: Non-small Cell Lung Cancer
Interventions: Drug: RO4929097; Drug: RO4929097
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Esophageal Cancer
Intervention:
Sponsors: Merck; World Health Information Science Consultants, LLC
Active, not recruiting - verified February 2010
Condition: Osteoporosis
Intervention: Drug: FORTEO
Sponsor: Eli Lilly and Company
Active, not recruiting - verified March 2010
Conditions: Renal Cell Cancer; Cancer
Intervention: Drug: Nelfinavir and temsirolimus
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified June 2009
Condition: Obesity
Interventions: Behavioral: training; Drug: nicotinic acid; Drug: Placebo
Sponsor: University Hospital, Toulouse
Recruiting - verified March 2010
Conditions: Smoking; Overweight; Obesity
Intervention: Other: The high protein diet group and the low fat diet group
Sponsor: Ullevaal University Hospital
Active, not recruiting - verified February 2010
Condition: Macular Degeneration
Interventions: Drug: pazopanib; Drug: pazopanib; Drug: pazopanib; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
